Latest filing published 16 Dec 2021 for 昭衍新药, €3.2M.
Filing timeline
BuySaleInsider track record
顾晓磊: trading record in brief
All filings by 顾晓磊 on record concern 昭衍新药, in the capacity of board member. We count 9 filings; the first trade dates from 31 May 2021 and the latest from 16 December 2021.
On the market, this insider has only sold: 9 sales, €30.6M in total.
On 16 December 2021 came the latest disclosure, an open-market sale for €3.2M in 昭衍新药. The median gap between trade and publication is zero days: most filings appear on the same day. The shorter that gap, the sooner other investors can see what insiders have done. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SSE / SZSE (CSRC) disclosures alone and does not predict where the share price will go.
Companies and markets linked to 顾晓磊
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 192,700 shares10.5% of flowA股XSHGSSE:173000005176769470
- 311,980 shares21.5% of flowA股XSHGSSE:173000004928452030
- 590,460 shares42.6% of flowA股XSHGSSE:173000004920314370
- 3,300 shares0.3% of flowA股XSHGSSE:173000004516388860
- 3,300 shares0.3% of flowA股XSHGSSE:173000004497422000
- 81,100 shares6.2% of flowA股XSHGSSE:173000004478509820
- 99,600 shares7.8% of flowA股XSHGSSE:173000004470624600
- 119,000 shares8.6% of flowA股XSHGSSE:173000004459202500
- 32,400 shares2.3% of flowA股XSHGSSE:173000004450722400
9 of 9 declarations